Antimalarial drug resistance: An overview
- PMID: 26998432
- PMCID: PMC4778180
- DOI: 10.4103/2229-5070.175081
Antimalarial drug resistance: An overview
Abstract
Malaria is a major public health burden throughout the world. Resistance to the antimalarial drugs has increased the mortality and morbidity rate that is achieved so far through the malaria control program. Monitoring the drug resistance to the available antimalarial drugs helps to implement effective drug policy, through the in vivo efficacy studies, in vitro drug susceptibility tests and detection of molecular markers. It is important to understand the mechanism of the antimalarial drugs, as it is one of the key factors in the emergence and spread of drug resistance. This review summarizes the commonly used antimalarial drugs, their mechanism of action and the genetic markers validated so far for the detection of drug-resistant parasites.
Keywords: Antimalarial drugs; Plasmodium falciparum; Plasmodium vivax; drug resistance markers; malaria.
Figures
References
-
- Farooq U, Mahajan RC. Drug resistance in malaria. J Vector Borne Dis. 2004;41:45–53. - PubMed
-
- Ballou WR, Hoffman SL, Sherwood JA, Hollingdale MR, Neva FA, Hockmeyer WT, et al. Safety and efficacy of a recombinant DNA Plasmodium falciparum sporozoite vaccine. Lancet. 1987;1:1277–81. - PubMed
-
- Payne D. Spread of chloroquine resistance in Plasmodium falciparum. Parasitol Today. 1987;3:241–6. - PubMed
-
- Petersen I, Eastman R, Lanzer M. Drug-resistant malaria: Molecular mechanisms and implications for public health. FEBS Lett. 2011;585:1551–62. - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources
